Neurontin and Factive drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Neurontin (gabapentin) and Factive (gemifloxacin mesylate). Common drug interactions include headache among females.
The phase IV clinical study analyzes what interactions people have when they take Neurontin and Factive. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Neurontin?
Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.
What is Factive?
Factive has active ingredients of gemifloxacin mesylate. eHealthMe is studying from 1,430 Factive users. Check the latest studies of Factive.
14 people who take Neurontin and Factive together, and have interactions are studied.

What are the common drug interactions of Neurontin and Factive, by gender? *:
female:
- Headache (pain in head)
- Fatigue (feeling of tiredness)
- Carotid artery stenosis (narrowing of carotid artery)
- Cellulitis (infection under the skin)
- Cerebral atrophy (decrement in size of brain)
- Chronic inflammatory demyelinating polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord)
- Colostomy
- Contusion (a type of hematoma of tissue in which capillaries)
- Deafness
- Depression
male:
n/a
What are the common drug interactions of Neurontin and Factive, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Back pain
- Flushing (the warm, red condition of human skin)
- Headache (pain in head)
- Impaired work ability
- Rash erythematous (redness of the skin)
- Rash generalised (rash on most of body parts)
- Surgery
- Urticaria (rash of round, red welts on the skin that itch intensely)
50-59:
- Headache (pain in head)
- Fatigue (feeling of tiredness)
- Back pain
- Impaired work ability
- Rash papular (redness with papule)
- Surgery
60+:
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Abscess oral (abscess in the mouth)
- Cerebral atrophy (decrement in size of brain)
- Chronic inflammatory demyelinating polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord)
- Colostomy
- Contusion (a type of hematoma of tissue in which capillaries)
- Deafness
- Depression
- Device failure
- Diarrhoea
What are the existing conditions these people have? *
- Respiratory Tract Infection Bacterial: 3 people, 21.43%
- Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 7.14%
- Pneumonia: 1 person, 7.14%
- Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 1 person, 7.14%
- Pain: 1 person, 7.14%
- High Blood Pressure: 1 person, 7.14%
- Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 7.14%
- Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 7.14%
- Diabetes: 1 person, 7.14%
- Chronic Kidney Disease: 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Neurontin and Factive?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Neurontin and Factive:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Neurontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Factive:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Neurontin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Factive and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin and gemifloxacin mesylate (the active ingredients of Neurontin and Factive, respectively), and Neurontin and Factive (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Nicotrol cause Weight Increased? - 31 seconds ago
- Drug interactions of Effexor Xr and Aspirin - 34 seconds ago
- Drug interactions of Provera and Naratriptan - 44 seconds ago
- Could Isovue-300 cause Chest Pain? - a minute ago
- Drug interactions of Sotalol Hydrochloride and Coumadin - a minute ago
- Could Acetaminophen cause Rash Erythematous? - a minute ago
- Could Glucophage cause Bleeding Into The Skin? - a minute ago
- Drug interactions of Soma and Nucynta Er - a minute ago
- Drug interactions of Apriso and Levothyroxine Sodium - 2 minutes ago
- Could Amitriptyline Hydrochloride cause Liver Function Test Abnormal? - 2 minutes ago